Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 8/2015

01.08.2015 | Demyelinating Disorders (DN Bourdette and M Cameron, Section Editors)

A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis

verfasst von: Michel Toledano, Brian G. Weinshenker, Andrew J. Solomon

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

The diagnostic criteria for multiple sclerosis (MS) rely on clinical, paraclinical, and radiographic findings of limited specificity. Many disorders mimic MS, and the decision of when to investigate an alternative diagnosis can be challenging. Reliance on extensive ancillary testing to exclude potential mimics, however, is unnecessary in most cases. Rather, recognition and rigorous interpretation of “classic” clinical and radiographic features of MS are often sufficient to establish the diagnosis. Misinterpretation of the clinical and radiographic diagnostic criteria for MS in the setting of more common diseases and syndromes and a lack of vigilance for “red flags” are important contributors to misdiagnosis. A clinical framework for the differential diagnosis of MS that emphasizes phenotypes atypical for MS and suggests diseases or syndromes in which they more commonly occur may be an important diagnostic guide for clinicians in contemporary practice.
Literatur
1.
Zurück zum Zitat Broman T, Bergmann L, Fog T, Gilland O, Hyllested K, Lindberg-Broman AM, et al. Aspects on classification methods in multiple sclerosis. Acta Neurol Scand Suppl. 1965;2:543–8. Broman T, Bergmann L, Fog T, Gilland O, Hyllested K, Lindberg-Broman AM, et al. Aspects on classification methods in multiple sclerosis. Acta Neurol Scand Suppl. 1965;2:543–8.
2.
Zurück zum Zitat Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227–31.PubMed Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227–31.PubMed
3.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50(1):121–7.PubMed McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50(1):121–7.PubMed
4.
Zurück zum Zitat Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58(6):840–6.PubMed Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58(6):840–6.PubMed
5.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.PubMedCentralPubMed Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.PubMedCentralPubMed
6.
Zurück zum Zitat Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology. 1996;47(1):145–8.PubMed Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology. 1996;47(1):145–8.PubMed
7.
Zurück zum Zitat Rodier G, Derouiche F, Bronner P, Cohen E. Eales disease with neurologic manifestation: differential diagnosis of multiple sclerosis. Report of two cases. Presse Med. 1999;28(31):1692–4.PubMed Rodier G, Derouiche F, Bronner P, Cohen E. Eales disease with neurologic manifestation: differential diagnosis of multiple sclerosis. Report of two cases. Presse Med. 1999;28(31):1692–4.PubMed
8.
Zurück zum Zitat Kraushar MF, Miller EM. Central serous choroidopathy misdiagnosed as a manifestation of multiple sclerosis. Ann Ophthalmol. 1982;14(3):215–8.PubMed Kraushar MF, Miller EM. Central serous choroidopathy misdiagnosed as a manifestation of multiple sclerosis. Ann Ophthalmol. 1982;14(3):215–8.PubMed
9.
Zurück zum Zitat Noseworthy JH, Rice GP. Trichlorethylene poisoning mimicking multiple sclerosis. Can J Neurol Sci. 1988;15(1):87–8.PubMed Noseworthy JH, Rice GP. Trichlorethylene poisoning mimicking multiple sclerosis. Can J Neurol Sci. 1988;15(1):87–8.PubMed
10.
Zurück zum Zitat Bender GP, Schapiro RT. Primary CNS lymphoma presenting as multiple sclerosis. A case study. Minn Med. 1989;72(3):157–60.PubMed Bender GP, Schapiro RT. Primary CNS lymphoma presenting as multiple sclerosis. A case study. Minn Med. 1989;72(3):157–60.PubMed
11.
Zurück zum Zitat Bussone G, La Mantia L, Grazzi L, Lamperti E, Salmaggi A, Strada L. Neurobrucellosis mimicking multiple sclerosis: a case report. Eur Neurol. 1989;29(4):238–40.PubMed Bussone G, La Mantia L, Grazzi L, Lamperti E, Salmaggi A, Strada L. Neurobrucellosis mimicking multiple sclerosis: a case report. Eur Neurol. 1989;29(4):238–40.PubMed
12.
Zurück zum Zitat Scott TF, Hess D, Brillman J. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Arch Intern Med. 1994;154(8):917–20.PubMed Scott TF, Hess D, Brillman J. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Arch Intern Med. 1994;154(8):917–20.PubMed
13.
Zurück zum Zitat Vrethem M, Thuomas KA, Hillman J. Cavernous angioma of the brain stem mimicking multiple sclerosis. N Engl J Med. 1997;336(12):875–6.PubMed Vrethem M, Thuomas KA, Hillman J. Cavernous angioma of the brain stem mimicking multiple sclerosis. N Engl J Med. 1997;336(12):875–6.PubMed
14.
Zurück zum Zitat Dougan CF, Coulthard A, Cartlidge NE, Burn DJ. Familial cavernous angiomas masquerading as multiple sclerosis. Postgrad Med J. 1998;74(874):489–91.PubMedCentralPubMed Dougan CF, Coulthard A, Cartlidge NE, Burn DJ. Familial cavernous angiomas masquerading as multiple sclerosis. Postgrad Med J. 1998;74(874):489–91.PubMedCentralPubMed
15.
Zurück zum Zitat Russo MB, Brooks FR, Fontenot J, Dopler BM, Neely ET, Halliday AW. Conversion disorder presenting as multiple sclerosis. Mil Med. 1998;163(10):709–10.PubMed Russo MB, Brooks FR, Fontenot J, Dopler BM, Neely ET, Halliday AW. Conversion disorder presenting as multiple sclerosis. Mil Med. 1998;163(10):709–10.PubMed
16.
Zurück zum Zitat Cader MZ, Winer JB. Lesson of the week: cavernous haemangioma mimicking multiple sclerosis. BMJ. 1999;318(7198):1604–5.PubMedCentralPubMed Cader MZ, Winer JB. Lesson of the week: cavernous haemangioma mimicking multiple sclerosis. BMJ. 1999;318(7198):1604–5.PubMedCentralPubMed
17.
Zurück zum Zitat Ormsby A, Prayson RA, Heard R. Angiotrophic large cell lymphoma mimicking multiple sclerosis associated transverse myelitis. J Clin Neurosci. 1999;6(5):408–10.PubMed Ormsby A, Prayson RA, Heard R. Angiotrophic large cell lymphoma mimicking multiple sclerosis associated transverse myelitis. J Clin Neurosci. 1999;6(5):408–10.PubMed
18.
Zurück zum Zitat Evans RW, Rolak LA. Migraine versus multiple sclerosis. Headache. 2001;41(1):97–8.PubMed Evans RW, Rolak LA. Migraine versus multiple sclerosis. Headache. 2001;41(1):97–8.PubMed
19.
Zurück zum Zitat O’Riordan S, Nor AM, Hutchinson M. CADASIL imitating multiple sclerosis: the importance of MRI markers. Mult Scler. 2002;8(5):430–2.PubMed O’Riordan S, Nor AM, Hutchinson M. CADASIL imitating multiple sclerosis: the importance of MRI markers. Mult Scler. 2002;8(5):430–2.PubMed
20.
Zurück zum Zitat Tiryaki E, Azzarelli B, Biller J. Superficial siderosis of the central nervous system in a patient with chronic subarachnoid hemorrhage misdiagnosed as multiple sclerosis. J Stroke Cerebrovasc Dis. 2002;11(5):288–9.PubMed Tiryaki E, Azzarelli B, Biller J. Superficial siderosis of the central nervous system in a patient with chronic subarachnoid hemorrhage misdiagnosed as multiple sclerosis. J Stroke Cerebrovasc Dis. 2002;11(5):288–9.PubMed
21.
Zurück zum Zitat Fernandez-Fernandez FJ, Rivera-Gallego A, de la Fuente-Aguado J, Perez-Fernandez S, Munoz-Fernandez D. Antiphospholipid syndrome mimicking multiple sclerosis in two patients. Eur J Intern Med. 2006;17(7):500–2.PubMed Fernandez-Fernandez FJ, Rivera-Gallego A, de la Fuente-Aguado J, Perez-Fernandez S, Munoz-Fernandez D. Antiphospholipid syndrome mimicking multiple sclerosis in two patients. Eur J Intern Med. 2006;17(7):500–2.PubMed
22.
Zurück zum Zitat Rafalowska J, Dziewulska D, Podlecka A, Zakrzewska-Pniewska B. Extensive mixed vascular malformation clinically imitating multiple sclerosis–case report. Clin Neuropathol. 2006;25(5):237–42.PubMed Rafalowska J, Dziewulska D, Podlecka A, Zakrzewska-Pniewska B. Extensive mixed vascular malformation clinically imitating multiple sclerosis–case report. Clin Neuropathol. 2006;25(5):237–42.PubMed
23.
Zurück zum Zitat Saip S, Uluduz D, Erkol G. Fabry disease mimicking multiple sclerosis. Clin Neurol Neurosurg. 2007;109(4):361–3.PubMed Saip S, Uluduz D, Erkol G. Fabry disease mimicking multiple sclerosis. Clin Neurol Neurosurg. 2007;109(4):361–3.PubMed
24.
Zurück zum Zitat Beeravolu LR, Frohman EM, Frohman TC, Remington GM, Lee S, Levin MC. Pearls & Oy-sters: “not multiple sclerosis” and the changing face of HTLV-1: a case report of downbeat nystagmus. Neurology. 2009;72(24):e119–20.PubMed Beeravolu LR, Frohman EM, Frohman TC, Remington GM, Lee S, Levin MC. Pearls & Oy-sters: “not multiple sclerosis” and the changing face of HTLV-1: a case report of downbeat nystagmus. Neurology. 2009;72(24):e119–20.PubMed
25.
Zurück zum Zitat Boentert M, Kraus J, Kloska S, Dittrich R, Nabavi DG, Niederstadt T, et al. Obliterating intracranial vasculopathy mimicking multiple sclerosis. Acta Neurol Scand. 2009;120(1):68–71.PubMed Boentert M, Kraus J, Kloska S, Dittrich R, Nabavi DG, Niederstadt T, et al. Obliterating intracranial vasculopathy mimicking multiple sclerosis. Acta Neurol Scand. 2009;120(1):68–71.PubMed
26.
Zurück zum Zitat Chebel S, Barboura I, Boughammoura-Bouatay A, Ammar M, Ferchichi S, Miled A, et al. Adult-type metachromatic leukodystrophy mimicking multiple sclerosis. Can J Neurol Sci. 2009;36(4):521–3.PubMed Chebel S, Barboura I, Boughammoura-Bouatay A, Ammar M, Ferchichi S, Miled A, et al. Adult-type metachromatic leukodystrophy mimicking multiple sclerosis. Can J Neurol Sci. 2009;36(4):521–3.PubMed
27.
Zurück zum Zitat Matsuo Y, Kamezaki K, Takeishi S, Takenaka K, Eto T, Nonami A, et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Intern Med. 2009;48(16):1453–6.PubMed Matsuo Y, Kamezaki K, Takeishi S, Takenaka K, Eto T, Nonami A, et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Intern Med. 2009;48(16):1453–6.PubMed
28.
Zurück zum Zitat Papadimas GK, Rentzos M, Zouvelou V, Kilidireas K, Konstantinopoulou A, Kokotis P, et al. Superficial siderosis of central nervous system mimicking multiple sclerosis. Neurologist. 2009;15(3):153–5.PubMed Papadimas GK, Rentzos M, Zouvelou V, Kilidireas K, Konstantinopoulou A, Kokotis P, et al. Superficial siderosis of central nervous system mimicking multiple sclerosis. Neurologist. 2009;15(3):153–5.PubMed
29.
Zurück zum Zitat Brinar VV, Habek M. Rare infections mimicking MS. Clin Neurol Neurosurg. 2010;112(7):625–8.PubMed Brinar VV, Habek M. Rare infections mimicking MS. Clin Neurol Neurosurg. 2010;112(7):625–8.PubMed
30.
Zurück zum Zitat Utsuki S, Oka H, Miyazaki T, Yamazaki T, Yasui Y, Fujii K, et al. Primary central nervous system large B-cell lymphoma with prolific, mixed T-cell and macrophage infiltrates, mimicking multiple sclerosis. Brain Tumor Pathol. 2010;27(1):59–63.PubMed Utsuki S, Oka H, Miyazaki T, Yamazaki T, Yasui Y, Fujii K, et al. Primary central nervous system large B-cell lymphoma with prolific, mixed T-cell and macrophage infiltrates, mimicking multiple sclerosis. Brain Tumor Pathol. 2010;27(1):59–63.PubMed
32.
Zurück zum Zitat Dorfman LJ, Fischbein NJ, Woodard JI, Choudhri O, Bell-Stephens TE, Steinberg GK. Moyamoya disease can masquerade as multiple sclerosis. Neurologist. 2012;18(6):398–403.PubMed Dorfman LJ, Fischbein NJ, Woodard JI, Choudhri O, Bell-Stephens TE, Steinberg GK. Moyamoya disease can masquerade as multiple sclerosis. Neurologist. 2012;18(6):398–403.PubMed
33.
Zurück zum Zitat Ohe Y, Hayashi T, Mishima K, Nishikawa R, Sasaki A, Matsuda H, et al. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy. Intern Med. 2013;52(4):483–8.PubMed Ohe Y, Hayashi T, Mishima K, Nishikawa R, Sasaki A, Matsuda H, et al. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy. Intern Med. 2013;52(4):483–8.PubMed
34.
Zurück zum Zitat Feasby TE, Hahn AF, Koopman WJ, Lee DH. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology. 1990;40(3 Pt 1):476–8.PubMed Feasby TE, Hahn AF, Koopman WJ, Lee DH. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology. 1990;40(3 Pt 1):476–8.PubMed
35.
Zurück zum Zitat Natowicz MR, Bejjani B. Genetic disorders that masquerade as multiple sclerosis. Am J Med Genet. 1994;49(2):149–69.PubMed Natowicz MR, Bejjani B. Genetic disorders that masquerade as multiple sclerosis. Am J Med Genet. 1994;49(2):149–69.PubMed
36.•
Zurück zum Zitat Solomon AJ, Weinshenker BG. Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep. 2013;13(12):013–0403. Solomon et al. provide a comprehensive summary of existing studies assessing the frequency and causes of MS misdiagnosis. Solomon AJ, Weinshenker BG. Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep. 2013;13(12):013–0403. Solomon et al. provide a comprehensive summary of existing studies assessing the frequency and causes of MS misdiagnosis.
37.
Zurück zum Zitat Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol. 2006;5(10):841–52.PubMed Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol. 2006;5(10):841–52.PubMed
38.
Zurück zum Zitat Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14(9):1157–74.PubMedCentralPubMed Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14(9):1157–74.PubMedCentralPubMed
39.
Zurück zum Zitat Poser CM, Brinar VV. Problems with diagnostic criteria for multiple sclerosis. Lancet. 2001;358(9295):1746–7.PubMed Poser CM, Brinar VV. Problems with diagnostic criteria for multiple sclerosis. Lancet. 2001;358(9295):1746–7.PubMed
40.••
Zurück zum Zitat Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand’Maison F, et al. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Neurology. 2012;79(23 Suppl 2):S1–15. Recent study that highlights limitations of MS imaging criteria. PubMed Selchen D, Bhan V, Blevins G, Devonshire V, Duquette P, Grand’Maison F, et al. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Neurology. 2012;79(23 Suppl 2):S1–15. Recent study that highlights limitations of MS imaging criteria. PubMed
41.
Zurück zum Zitat Ebers GC. Natural history of primary progressive multiple sclerosis. Mult Scler. 2004;10(1):S13–5. Ebers GC. Natural history of primary progressive multiple sclerosis. Mult Scler. 2004;10(1):S13–5.
42.
Zurück zum Zitat Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800–5.PubMed Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800–5.PubMed
43.
Zurück zum Zitat Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014;9(3):e90509. Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014;9(3):e90509.
44.
Zurück zum Zitat Bourdette D, Yadav V. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no. Mult Scler. 2012;18(11):1529–30.PubMed Bourdette D, Yadav V. Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no. Mult Scler. 2012;18(11):1529–30.PubMed
45.
Zurück zum Zitat Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013;84(8):909–14.PubMed Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013;84(8):909–14.PubMed
46.
Zurück zum Zitat Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(9):1720–5.PubMed Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(9):1720–5.PubMed
47.
Zurück zum Zitat Goodman AD, Mattson DH. Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology. 1995;45(2):384–5.PubMed Goodman AD, Mattson DH. Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology. 1995;45(2):384–5.PubMed
48.
Zurück zum Zitat Magro Checa C, Cohen D, Bollen EL, van Buchem MA, Huizinga TW, Steup-Beekman GM. Demyelinating disease in SLE: is it multiple sclerosis or lupus? Best Pract Res Clin Rheumatol. 2013;27(3):405–24.PubMed Magro Checa C, Cohen D, Bollen EL, van Buchem MA, Huizinga TW, Steup-Beekman GM. Demyelinating disease in SLE: is it multiple sclerosis or lupus? Best Pract Res Clin Rheumatol. 2013;27(3):405–24.PubMed
49.
Zurück zum Zitat Roussel V, Yi F, Jauberteau MO, Couderq C, Lacombe C, Michelet V, et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun. 2000;14(3):259–65.PubMed Roussel V, Yi F, Jauberteau MO, Couderq C, Lacombe C, Michelet V, et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun. 2000;14(3):259–65.PubMed
50.
Zurück zum Zitat Heinzlef O, Weill B, Johanet C, Sazdovitch V, Caillat-Zucman S, Tournier-Lasserve E, et al. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry. 2002;72(5):647–9.PubMedCentralPubMed Heinzlef O, Weill B, Johanet C, Sazdovitch V, Caillat-Zucman S, Tournier-Lasserve E, et al. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry. 2002;72(5):647–9.PubMedCentralPubMed
51.
Zurück zum Zitat Solomon AJ, Hills W, Chen Z, Rosenbaum J, Bourdette D, Whitham R. Autoantibodies and Sjogren’s Syndrome in multiple sclerosis, a reappraisal. PLoS One. 2013;8(6):e65385. Solomon AJ, Hills W, Chen Z, Rosenbaum J, Bourdette D, Whitham R. Autoantibodies and Sjogren’s Syndrome in multiple sclerosis, a reappraisal. PLoS One. 2013;8(6):e65385.
52.
Zurück zum Zitat de Andres C, Guillem A, Rodriguez-Mahou M, Lopez Longo FJ. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. Acta Neurol Scand. 2001;104(2):83–7.PubMed de Andres C, Guillem A, Rodriguez-Mahou M, Lopez Longo FJ. Frequency and significance of anti-Ro (SS-A) antibodies in multiple sclerosis patients. Acta Neurol Scand. 2001;104(2):83–7.PubMed
53.
Zurück zum Zitat Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol. 1991;109:1673–8. Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch Ophthalmol. 1991;109:1673–8.
54.
Zurück zum Zitat Sibony P, Halperin J, Coyle PK, Patel K. Reactive Lyme serology in optic neuritis. J Neuroophthalmol. 2005;25(2):71–82.PubMed Sibony P, Halperin J, Coyle PK, Patel K. Reactive Lyme serology in optic neuritis. J Neuroophthalmol. 2005;25(2):71–82.PubMed
55.
Zurück zum Zitat Coyle PK, Krupp LB, Doscher C. Significance of reactive Lyme serology in multiple sclerosis. Ann Neurol. 1993;34(5):745–7.PubMed Coyle PK, Krupp LB, Doscher C. Significance of reactive Lyme serology in multiple sclerosis. Ann Neurol. 1993;34(5):745–7.PubMed
56.
Zurück zum Zitat Reynolds EH, Bottiglieri T, Laundy M, Crellin RF, Kirker SG. Vitamin B12 metabolism in multiple sclerosis. Arch Neurol. 1992;49(6):649–52.PubMed Reynolds EH, Bottiglieri T, Laundy M, Crellin RF, Kirker SG. Vitamin B12 metabolism in multiple sclerosis. Arch Neurol. 1992;49(6):649–52.PubMed
57.
Zurück zum Zitat Goodkin DE, Jacobsen DW, Galvez N, Daughtry M, Secic M, Green R. Serum cobalamin deficiency is uncommon in multiple sclerosis. Arch Neurol. 1994;51(11):1110–4.PubMed Goodkin DE, Jacobsen DW, Galvez N, Daughtry M, Secic M, Green R. Serum cobalamin deficiency is uncommon in multiple sclerosis. Arch Neurol. 1994;51(11):1110–4.PubMed
58.
Zurück zum Zitat Murray TJ, Murray SJ. Characteristics of patients found not to have multiple sclerosis. Can Med Assoc J. 1984;131(4):336–7.PubMedCentralPubMed Murray TJ, Murray SJ. Characteristics of patients found not to have multiple sclerosis. Can Med Assoc J. 1984;131(4):336–7.PubMedCentralPubMed
59.
Zurück zum Zitat Carmosino MJ, Brousseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol. 2005;62(4):585–90.PubMed Carmosino MJ, Brousseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol. 2005;62(4):585–90.PubMed
60.
Zurück zum Zitat Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist. 2007;13(2):57–72.PubMed Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist. 2007;13(2):57–72.PubMed
61.
Zurück zum Zitat Solomon AJ, Klein EP, Bourdette D. “Undiagnosing” multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012;78(24):1986–91.PubMedCentralPubMed Solomon AJ, Klein EP, Bourdette D. “Undiagnosing” multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012;78(24):1986–91.PubMedCentralPubMed
62.
Zurück zum Zitat Poser CM. Misdiagnosis of multiple sclerosis and beta-interferon. Lancet. 1997;349(9069):1916.PubMed Poser CM. Misdiagnosis of multiple sclerosis and beta-interferon. Lancet. 1997;349(9069):1916.PubMed
63.
Zurück zum Zitat Wingerchuk DM, Banwell B, Jeffrey BL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015. doi:10.1212/WNL.0000000000001729. Wingerchuk DM, Banwell B, Jeffrey BL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015. doi:10.​1212/​WNL.​0000000000001729​.
64.
Zurück zum Zitat Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BM, Polman CH. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol. 2005;58(5):781–3.PubMed Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BM, Polman CH. Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol. 2005;58(5):781–3.PubMed
65.
Zurück zum Zitat Whiting P, Harbord R, Main C, Deeks JJ, Filippini G, Egger M, et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ. 2006;332(7546):875–84.PubMedCentralPubMed Whiting P, Harbord R, Main C, Deeks JJ, Filippini G, Egger M, et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ. 2006;332(7546):875–84.PubMedCentralPubMed
66.
Zurück zum Zitat Schiffer RB, Giang DW, Mushlin A, Ketonen L, Joy S, Kido D, et al. Perils and pitfalls of magnetic resonance imaging in the diagnosis of multiple sclerosis. The Rochester-Toronto MRI Study Group. J Neuroimaging. 1993;3(2):81–8.PubMed Schiffer RB, Giang DW, Mushlin A, Ketonen L, Joy S, Kido D, et al. Perils and pitfalls of magnetic resonance imaging in the diagnosis of multiple sclerosis. The Rochester-Toronto MRI Study Group. J Neuroimaging. 1993;3(2):81–8.PubMed
67.
Zurück zum Zitat Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.
68.•
Zurück zum Zitat Liu S, Kullnat J, Bourdette D, Simon J, Kraemer DF, Murchison C, et al. Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler. 2013;19(8):1101–5. Recent study that highlights limitations of MS imaging criteria. PubMed Liu S, Kullnat J, Bourdette D, Simon J, Kraemer DF, Murchison C, et al. Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler. 2013;19(8):1101–5. Recent study that highlights limitations of MS imaging criteria. PubMed
69.
Zurück zum Zitat Carson AJ, Best S, Postma K, Stone J, Warlow C, Sharpe M. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry. 2003;74(7):897–900.PubMedCentralPubMed Carson AJ, Best S, Postma K, Stone J, Warlow C, Sharpe M. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry. 2003;74(7):897–900.PubMedCentralPubMed
70.
Zurück zum Zitat Stone J, Carson A, Duncan R, Coleman R, Roberts R, Warlow C, et al. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(Pt 10):2878–88.PubMed Stone J, Carson A, Duncan R, Coleman R, Roberts R, Warlow C, et al. Symptoms ‘unexplained by organic disease’ in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(Pt 10):2878–88.PubMed
71.
Zurück zum Zitat Boster A, Caon C, Perumal J, Hreha S, Zabad R, Zak I, et al. Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence. Mult Scler. 2008;14(6):804–8.PubMed Boster A, Caon C, Perumal J, Hreha S, Zabad R, Zak I, et al. Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence. Mult Scler. 2008;14(6):804–8.PubMed
72.
Zurück zum Zitat Arnold AC. Ischemic optic neuropathies. Ophthalmol Clin N Am. 2001;14(1):83–98. Arnold AC. Ischemic optic neuropathies. Ophthalmol Clin N Am. 2001;14(1):83–98.
73.
Zurück zum Zitat Rubin MN, Rabinstein AA. Vascular diseases of the spinal cord. Neurol Clin. 2013;31(1):153–81.PubMed Rubin MN, Rabinstein AA. Vascular diseases of the spinal cord. Neurol Clin. 2013;31(1):153–81.PubMed
74.
Zurück zum Zitat Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707–10.PubMed Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707–10.PubMed
75.
Zurück zum Zitat Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44(5):731–9.PubMed Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44(5):731–9.PubMed
76.
Zurück zum Zitat O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56(5):628–34.PubMed O’Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56(5):628–34.PubMed
77.
Zurück zum Zitat Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001;218(2):443–51.PubMed Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001;218(2):443–51.PubMed
78.
Zurück zum Zitat Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53(5):1107–14.PubMed Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53(5):1107–14.PubMed
79.
Zurück zum Zitat Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology. 2005;65(9):1479–82.PubMed Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology. 2005;65(9):1479–82.PubMed
80.
Zurück zum Zitat Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010;68(5):757–61.PubMed Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010;68(5):757–61.PubMed
81.
Zurück zum Zitat Flanagan EP, Weinshenker BG. Neuromyelitis optica spectrum disorders. Curr Neurol Neurosci Rep. 2014;14(9):014–0483. Flanagan EP, Weinshenker BG. Neuromyelitis optica spectrum disorders. Curr Neurol Neurosci Rep. 2014;14(9):014–0483.
82.
Zurück zum Zitat Downer JJ, Leite MI, Carter R, Palace J, Kuker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? Neuroradiology. 2012;54(4):279–85.PubMed Downer JJ, Leite MI, Carter R, Palace J, Kuker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? Neuroradiology. 2012;54(4):279–85.PubMed
83.
Zurück zum Zitat Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81–7.PubMed Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81–7.PubMed
84.
Zurück zum Zitat Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. “Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009;66(3):425–8.PubMed Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. “Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009;66(3):425–8.PubMed
85.
Zurück zum Zitat Eichel R, Meiner Z, Abramsky O, Gotkine M. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol. 2008;65(2):267–71.PubMed Eichel R, Meiner Z, Abramsky O, Gotkine M. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol. 2008;65(2):267–71.PubMed
86.
Zurück zum Zitat Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, Kuwabara S. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler. 2013;19(3):308–15.PubMed Makino T, Ito S, Mori M, Yonezu T, Ogawa Y, Kuwabara S. Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica. Mult Scler. 2013;19(3):308–15.PubMed
87.
Zurück zum Zitat Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011;306(1-2):82–90.PubMed Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011;306(1-2):82–90.PubMed
88.
Zurück zum Zitat Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013;81(14):1197–204.PubMedCentralPubMed Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013;81(14):1197–204.PubMedCentralPubMed
89.
Zurück zum Zitat Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012;78(9):665–71.PubMedCentralPubMed Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012;78(9):665–71.PubMedCentralPubMed
90.
Zurück zum Zitat Sandberg-Wollheim M, Axell T, Hansen BU, Henricsson V, Ingesson E, Jacobsson L, et al. Primary Sjogren’s syndrome in patients with multiple sclerosis. Neurology. 1992;42(4):845–7.PubMed Sandberg-Wollheim M, Axell T, Hansen BU, Henricsson V, Ingesson E, Jacobsson L, et al. Primary Sjogren’s syndrome in patients with multiple sclerosis. Neurology. 1992;42(4):845–7.PubMed
91.••
Zurück zum Zitat Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler. 2012;18(1):5–10. The authors summarize recent studies addressing the relationship between NMO and rheumatologic disease. They conclude that current evidence supports the hypothesis that NMO is one manifestation of a genetic tendency toward humoral autoimmunity rather than a nervous system complication of rheumatologic disease. PubMed Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler. 2012;18(1):5–10. The authors summarize recent studies addressing the relationship between NMO and rheumatologic disease. They conclude that current evidence supports the hypothesis that NMO is one manifestation of a genetic tendency toward humoral autoimmunity rather than a nervous system complication of rheumatologic disease. PubMed
92.
Zurück zum Zitat Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev. 2015;14(2):153–9.PubMed Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev. 2015;14(2):153–9.PubMed
93.
Zurück zum Zitat Tzarouchi LC, Tsifetaki N, Konitsiotis S, Zikou A, Astrakas L, Drosos A, et al. CNS involvement in primary Sjogren syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry. AJR Am J Roentgenol. 2011;197(5):1207–12.PubMed Tzarouchi LC, Tsifetaki N, Konitsiotis S, Zikou A, Astrakas L, Drosos A, et al. CNS involvement in primary Sjogren syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry. AJR Am J Roentgenol. 2011;197(5):1207–12.PubMed
94.
Zurück zum Zitat Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin. 2013;31(1):79–138.PubMed Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin. 2013;31(1):79–138.PubMed
95.
Zurück zum Zitat Seifert T, Enzinger C, Ropele S, Storch MK, Strasser-Fuchs S, Fazekas F. Relapsing acute transverse myelitis: a specific entity. Eur J Neurol. 2005;12(9):681–4.PubMed Seifert T, Enzinger C, Ropele S, Storch MK, Strasser-Fuchs S, Fazekas F. Relapsing acute transverse myelitis: a specific entity. Eur J Neurol. 2005;12(9):681–4.PubMed
96.
Zurück zum Zitat Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain. 1993;116(Pt 1):135–46.PubMed Morrissey SP, Miller DH, Kendall BE, Kingsley DP, Kelly MA, Francis DA, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain. 1993;116(Pt 1):135–46.PubMed
97.
Zurück zum Zitat Scott TF, Kassab SL, Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler. 2005;11(4):373–7.PubMed Scott TF, Kassab SL, Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler. 2005;11(4):373–7.PubMed
98.••
Zurück zum Zitat Rostasy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler. 2013;19(8):1052–9.PubMed Rostasy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler. 2013;19(8):1052–9.PubMed
99.••
Zurück zum Zitat Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3):276–83.PubMed Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3):276–83.PubMed
100.••
Zurück zum Zitat Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82(6):474–81.PubMedCentralPubMed Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82(6):474–81.PubMedCentralPubMed
101.••
Zurück zum Zitat Probstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, et al. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation. 2015;12(1):46. The above independently conducted studies provide evidence that a subset of patients with an aquaporin-4 antibody negative neuromyelitis optica phenotype harbor antibodies to myelin-oligodendrocyte glycoprotein. PubMedCentralPubMed Probstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, et al. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation. 2015;12(1):46. The above independently conducted studies provide evidence that a subset of patients with an aquaporin-4 antibody negative neuromyelitis optica phenotype harbor antibodies to myelin-oligodendrocyte glycoprotein. PubMedCentralPubMed
102.
Zurück zum Zitat Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation. Brain. 1992;115(Pt 4):979–89.PubMed Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber’s hereditary optic neuropathy mitochondrial DNA mutation. Brain. 1992;115(Pt 4):979–89.PubMed
103.
Zurück zum Zitat Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE. Leber’s hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol. 1994;36(1):109–12.PubMed Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE. Leber’s hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol. 1994;36(1):109–12.PubMed
104.
Zurück zum Zitat Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol. 1999;19(1):28–33.PubMed Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol. 1999;19(1):28–33.PubMed
105.
Zurück zum Zitat Merwick A, Sweeney BJ. Functional symptoms in clinically definite MS–pseudo-relapse syndrome. Int MS J. 2008;15(2):47–51.PubMed Merwick A, Sweeney BJ. Functional symptoms in clinically definite MS–pseudo-relapse syndrome. Int MS J. 2008;15(2):47–51.PubMed
106.
Zurück zum Zitat Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010;81(1):109–11.PubMed Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010;81(1):109–11.PubMed
107.
Zurück zum Zitat Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain. 2003;126(Pt 2):276–84.PubMed Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain. 2003;126(Pt 2):276–84.PubMed
108.••
Zurück zum Zitat Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2014;261(1):17–26. A recent systematic literature review of all reported cases of chronic relapsing inflammatory optic neuropathy (CRION). The authors argue that CRION is a distinct nosological entity and propose new diagnostic criteria in view of collected data. PubMed Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol. 2014;261(1):17–26. A recent systematic literature review of all reported cases of chronic relapsing inflammatory optic neuropathy (CRION). The authors argue that CRION is a distinct nosological entity and propose new diagnostic criteria in view of collected data. PubMed
109.
Zurück zum Zitat Zadro I, Barun B, Habek M, Brinar VV. Isolated cranial nerve palsies in multiple sclerosis. Clin Neurol Neurosurg. 2008;110(9):886–8.PubMed Zadro I, Barun B, Habek M, Brinar VV. Isolated cranial nerve palsies in multiple sclerosis. Clin Neurol Neurosurg. 2008;110(9):886–8.PubMed
110.
Zurück zum Zitat Thomke F, Lensch E, Ringel K, Hopf HC. Isolated cranial nerve palsies in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997;63(5):682–5.PubMedCentralPubMed Thomke F, Lensch E, Ringel K, Hopf HC. Isolated cranial nerve palsies in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997;63(5):682–5.PubMedCentralPubMed
111.
Zurück zum Zitat Uzawa A, Mori M, Ito S, Kuwabara S. Neurological picture. Isolated abducens and facial nerve palsies due to a facial collicular plaque in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(1):85–6.PubMed Uzawa A, Mori M, Ito S, Kuwabara S. Neurological picture. Isolated abducens and facial nerve palsies due to a facial collicular plaque in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(1):85–6.PubMed
112.
Zurück zum Zitat Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42(9):909–17.PubMed Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42(9):909–17.PubMed
113.
Zurück zum Zitat Burns TM. Neurosarcoidosis. Arch Neurol. 2003;60(8):1166–8.PubMed Burns TM. Neurosarcoidosis. Arch Neurol. 2003;60(8):1166–8.PubMed
114.
Zurück zum Zitat Stern BJ, Aksamit A, Clifford D, Scott TF. Neurologic presentations of sarcoidosis. Neurol Clin. 2010;28(1):185–98.PubMed Stern BJ, Aksamit A, Clifford D, Scott TF. Neurologic presentations of sarcoidosis. Neurol Clin. 2010;28(1):185–98.PubMed
115.
Zurück zum Zitat Terushkin V, Stern BJ, Judson MA, Hagiwara M, Pramanik B, Sanchez M, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16(1):2–15.PubMed Terushkin V, Stern BJ, Judson MA, Hagiwara M, Pramanik B, Sanchez M, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16(1):2–15.PubMed
116.
Zurück zum Zitat Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM. 2009;102(7):449–60.PubMed Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM. 2009;102(7):449–60.PubMed
117.
Zurück zum Zitat Bakshi R, Minagar A, Jaisani Z, Wolinsky JS. Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx. 2005;2(2):277–303.PubMedCentralPubMed Bakshi R, Minagar A, Jaisani Z, Wolinsky JS. Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx. 2005;2(2):277–303.PubMedCentralPubMed
118.
Zurück zum Zitat Goenka N, Venna N. Teaching neuroimages: sarcoidosis presenting as longitudinally extensive myelitis: excellent response to infliximab. Neurology. 2013;81(9):e61.PubMed Goenka N, Venna N. Teaching neuroimages: sarcoidosis presenting as longitudinally extensive myelitis: excellent response to infliximab. Neurology. 2013;81(9):e61.PubMed
119.
Zurück zum Zitat Kobayashi S, Nakata W, Sugimoto H. Spinal magnetic resonance imaging manifestations at neurological onset in Japanese patients with spinal cord sarcoidosis. Intern Med. 2013;52(18):2041–50.PubMed Kobayashi S, Nakata W, Sugimoto H. Spinal magnetic resonance imaging manifestations at neurological onset in Japanese patients with spinal cord sarcoidosis. Intern Med. 2013;52(18):2041–50.PubMed
120.
Zurück zum Zitat Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry. 2009;80(3):297–304.PubMed Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry. 2009;80(3):297–304.PubMed
121.
Zurück zum Zitat Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist. 2009;15(2):108–11.PubMed Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist. 2009;15(2):108–11.PubMed
122.
Zurück zum Zitat Keijsers RG, Grutters JC, Thomeer M, Du Bois RM, Van Buul MM, Lavalaye J, et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. Q J Nucl Med Mol Imaging. 2011;55(1):66–71.PubMed Keijsers RG, Grutters JC, Thomeer M, Du Bois RM, Van Buul MM, Lavalaye J, et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. Q J Nucl Med Mol Imaging. 2011;55(1):66–71.PubMed
123.
Zurück zum Zitat Huang JF, Aksamit AJ, Staff NP. MRI and PET imaging discordance in neurosarcoidosis. Neurology. 2012;79(10):1070.PubMed Huang JF, Aksamit AJ, Staff NP. MRI and PET imaging discordance in neurosarcoidosis. Neurology. 2012;79(10):1070.PubMed
124.
Zurück zum Zitat Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O’Neill BP, et al. (18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013;88(11):1204–12.PubMed Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O’Neill BP, et al. (18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013;88(11):1204–12.PubMed
125.
Zurück zum Zitat Halperin JJ. Nervous system Lyme disease: diagnosis and treatment. Curr Treat Options Neurol. 2013;15(4):454–64.PubMed Halperin JJ. Nervous system Lyme disease: diagnosis and treatment. Curr Treat Options Neurol. 2013;15(4):454–64.PubMed
126.
Zurück zum Zitat Oksi J, Kalimo H, Marttila RJ, Marjamaki M, Sonninen P, Nikoskelainen J, et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain. 1996;119(Pt 6):2143–54.PubMed Oksi J, Kalimo H, Marttila RJ, Marjamaki M, Sonninen P, Nikoskelainen J, et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain. 1996;119(Pt 6):2143–54.PubMed
127.
Zurück zum Zitat Fernandez RE, Rothberg M, Ferencz G, Wujack D. Lyme disease of the CNS: MR imaging findings in 14 cases. AJNR Am J Neuroradiol. 1990;11(3):479–81.PubMed Fernandez RE, Rothberg M, Ferencz G, Wujack D. Lyme disease of the CNS: MR imaging findings in 14 cases. AJNR Am J Neuroradiol. 1990;11(3):479–81.PubMed
128.
Zurück zum Zitat Kruger H, Heim E, Schuknecht B, Scholz S. Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J Neurol. 1991;238(5):271–80.PubMed Kruger H, Heim E, Schuknecht B, Scholz S. Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J Neurol. 1991;238(5):271–80.PubMed
129.
Zurück zum Zitat Belman AL, Coyle PK, Roque C, Cantos E. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol. 1992;8(6):428–31.PubMed Belman AL, Coyle PK, Roque C, Cantos E. MRI findings in children infected by Borrelia burgdorferi. Pediatr Neurol. 1992;8(6):428–31.PubMed
130.
Zurück zum Zitat Rafto SE, Milton WJ, Galetta SL. GRI Biopsy-confirmed CNS Lyme disease: MR appearance at 1.5 T. AJNR Am J Neuroradiol. 1990;11(3):482–4.PubMed Rafto SE, Milton WJ, Galetta SL. GRI Biopsy-confirmed CNS Lyme disease: MR appearance at 1.5 T. AJNR Am J Neuroradiol. 1990;11(3):482–4.PubMed
131.
Zurück zum Zitat Agosta F, Rocca MA, Benedetti B, Capra R, Cordioli C, Filippi M. MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. AJNR Am J Neuroradiol. 2006;27(4):892–4.PubMed Agosta F, Rocca MA, Benedetti B, Capra R, Cordioli C, Filippi M. MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. AJNR Am J Neuroradiol. 2006;27(4):892–4.PubMed
132.
Zurück zum Zitat Agarwal R, Sze G. Neuro-lyme disease: MR imaging findings. Radiology. 2009;253(1):167–73.PubMed Agarwal R, Sze G. Neuro-lyme disease: MR imaging findings. Radiology. 2009;253(1):167–73.PubMed
133.
Zurück zum Zitat Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008;131(Pt 7):1759–75.PubMedCentralPubMed Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008;131(Pt 7):1759–75.PubMedCentralPubMed
134.
Zurück zum Zitat Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261–7.PubMed Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261–7.PubMed
135.
Zurück zum Zitat Wingerchuk DM, Weinshenker BG. Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica. Continuum. 2013;19(4 Multiple Sclerosis):944–67.PubMed Wingerchuk DM, Weinshenker BG. Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica. Continuum. 2013;19(4 Multiple Sclerosis):944–67.PubMed
136.
Zurück zum Zitat Bester M, Petracca M, Inglese M. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Semin Roentgenol. 2014;49(1):76–85.PubMed Bester M, Petracca M, Inglese M. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Semin Roentgenol. 2014;49(1):76–85.PubMed
137.
Zurück zum Zitat Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arthritis Rheum. 1997;40(7):1189–201.PubMed Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arthritis Rheum. 1997;40(7):1189–201.PubMed
138.
Zurück zum Zitat Salvarani C, Brown Jr RD, Hunder GG. Adult primary central nervous system vasculitis. Lancet. 2012;380(9843):767–77.PubMed Salvarani C, Brown Jr RD, Hunder GG. Adult primary central nervous system vasculitis. Lancet. 2012;380(9843):767–77.PubMed
139.
Zurück zum Zitat Zuccoli G, Pipitone N, Haldipur A, Brown Jr RD, Hunder G, Salvarani C. Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol. 2011;29(1 Suppl 64):11. Zuccoli G, Pipitone N, Haldipur A, Brown Jr RD, Hunder G, Salvarani C. Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol. 2011;29(1 Suppl 64):11.
140.
Zurück zum Zitat Buzzard KA, Reddel SW, Yiannikas C, Sean Riminton D, Barnett MH, Hardy TA. Distinguishing Susac’s syndrome from multiple sclerosis. J Neurol. 2014;30:30. Buzzard KA, Reddel SW, Yiannikas C, Sean Riminton D, Barnett MH, Hardy TA. Distinguishing Susac’s syndrome from multiple sclerosis. J Neurol. 2014;30:30.
141.
Zurück zum Zitat Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, et al. MRI findings in Susac’s syndrome. Neurology. 2003;61(12):1783–7.PubMed Susac JO, Murtagh FR, Egan RA, Berger JR, Bakshi R, Lincoff N, et al. MRI findings in Susac’s syndrome. Neurology. 2003;61(12):1783–7.PubMed
142.
Zurück zum Zitat Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol. 2001;11(4):440–51.PubMed Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol. 2001;11(4):440–51.PubMed
143.
Zurück zum Zitat Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep. 2009;9(6):430–4.PubMed Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep. 2009;9(6):430–4.PubMed
144.
Zurück zum Zitat Verhey LH, Banwell BL. Inflammatory, vascular, and infectious myelopathies in children. Handb Clin Neurol. 2013;112:999–1017.PubMed Verhey LH, Banwell BL. Inflammatory, vascular, and infectious myelopathies in children. Handb Clin Neurol. 2013;112:999–1017.PubMed
145.
Zurück zum Zitat Berger JR, Fee DB, Nelson P, Nuovo G. Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness. J Neurovirol. 2009;15(3):282–7.PubMed Berger JR, Fee DB, Nelson P, Nuovo G. Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness. J Neurovirol. 2009;15(3):282–7.PubMed
146.
Zurück zum Zitat Hart Jr J, Tillman G, Kraut MA, Chiang HS, Strain JF, Li Y, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14(248):1471–2334. Hart Jr J, Tillman G, Kraut MA, Chiang HS, Strain JF, Li Y, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14(248):1471–2334.
147.
Zurück zum Zitat Marra CM. Neurologic complications of Bartonella henselae infection. Curr Opin Neurol. 1995;8(3):164–9.PubMed Marra CM. Neurologic complications of Bartonella henselae infection. Curr Opin Neurol. 1995;8(3):164–9.PubMed
148.
Zurück zum Zitat Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis. 1993;17(1):S52–7.PubMed Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis. 1993;17(1):S52–7.PubMed
149.
Zurück zum Zitat Pruitt AA. Infections of the nervous system. Neurol Clin. 1998;16(2):419–47.PubMed Pruitt AA. Infections of the nervous system. Neurol Clin. 1998;16(2):419–47.PubMed
150.
Zurück zum Zitat Devere TR, Trotter JL, Cross AH. Acute aphasia in multiple sclerosis. Arch Neurol. 2000;57(8):1207–9.PubMed Devere TR, Trotter JL, Cross AH. Acute aphasia in multiple sclerosis. Arch Neurol. 2000;57(8):1207–9.PubMed
151.
Zurück zum Zitat Puthenparampil M, Poggiali D, Causin F, Rolma G, Rinaldi F, Perini P, et al. Cortical relapses in multiple sclerosis. Mult Scler. 2015;19:1352458514564483. Puthenparampil M, Poggiali D, Causin F, Rolma G, Rinaldi F, Perini P, et al. Cortical relapses in multiple sclerosis. Mult Scler. 2015;19:1352458514564483.
152.
Zurück zum Zitat Koch M, Kingwell E, Rieckmann P, Tremlett H. The natural history of primary progressive multiple sclerosis. Neurology. 2009;73(23):1996–2002.PubMed Koch M, Kingwell E, Rieckmann P, Tremlett H. The natural history of primary progressive multiple sclerosis. Neurology. 2009;73(23):1996–2002.PubMed
153.
Zurück zum Zitat Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin. 2010;28(1):107–70.PubMed Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin. 2010;28(1):107–70.PubMed
154.
Zurück zum Zitat Bilgrami M, O’Keefe P. Neurologic diseases in HIV-infected patients. Handb Clin Neurol. 2014;121:1321–44.PubMed Bilgrami M, O’Keefe P. Neurologic diseases in HIV-infected patients. Handb Clin Neurol. 2014;121:1321–44.PubMed
155.
Zurück zum Zitat Araujo AQ. Update on Neurological Manifestations of HTLV-1 Infection. Curr Infect Dis Rep. 2015;17(2):014–0459. Araujo AQ. Update on Neurological Manifestations of HTLV-1 Infection. Curr Infect Dis Rep. 2015;17(2):014–0459.
156.
Zurück zum Zitat Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388.PubMedCentralPubMed Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3:388.PubMedCentralPubMed
157.
Zurück zum Zitat Muralidharan R, Saladino A, Lanzino G, Atkinson JL, Rabinstein AA. The clinical and radiological presentation of spinal dural arteriovenous fistula. Spine. 1976;36(25):E1641–7. Muralidharan R, Saladino A, Lanzino G, Atkinson JL, Rabinstein AA. The clinical and radiological presentation of spinal dural arteriovenous fistula. Spine. 1976;36(25):E1641–7.
158.
Zurück zum Zitat Gilbertson JR, Miller GM, Goldman MS, Marsh WR. Spinal dural arteriovenous fistulas: MR and myelographic findings. AJNR Am J Neuroradiol. 1995;16(10):2049–57.PubMed Gilbertson JR, Miller GM, Goldman MS, Marsh WR. Spinal dural arteriovenous fistulas: MR and myelographic findings. AJNR Am J Neuroradiol. 1995;16(10):2049–57.PubMed
159.
Zurück zum Zitat Denora PS, Santorelli FM, Bertini E. Hereditary spastic paraplegias: one disease for many genes, and still counting. Handb Clin Neurol. 2013;113:1899–912.PubMed Denora PS, Santorelli FM, Bertini E. Hereditary spastic paraplegias: one disease for many genes, and still counting. Handb Clin Neurol. 2013;113:1899–912.PubMed
160.
Zurück zum Zitat Tartaglia M, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol. 2007;64(2):232–6. doi:10.1001/archneur.64.2.232.PubMed Tartaglia M, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol. 2007;64(2):232–6. doi:10.​1001/​archneur.​64.​2.​232.PubMed
161.
Zurück zum Zitat Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9(1):94–104.PubMed Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9(1):94–104.PubMed
162.•
Zurück zum Zitat Weisfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD. Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain. 2015;138(Pt 3):517–39. An updated overview of the clinical and investigational characteristics of single gene disorders with the potential to mimic MS. PubMed Weisfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD. Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain. 2015;138(Pt 3):517–39. An updated overview of the clinical and investigational characteristics of single gene disorders with the potential to mimic MS. PubMed
163.
Zurück zum Zitat Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry. 2003;74(7):872–7.PubMedCentralPubMed Zarei M, Chandran S, Compston A, Hodges J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry. 2003;74(7):872–7.PubMedCentralPubMed
164.
Zurück zum Zitat Staff NP, Lucchinetti CF, Keegan BM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol. 2009;66(9):1139–43.PubMedCentralPubMed Staff NP, Lucchinetti CF, Keegan BM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol. 2009;66(9):1139–43.PubMedCentralPubMed
165.
Zurück zum Zitat Calabrese P, Penner IK. Cognitive dysfunctions in multiple sclerosis–a “multiple disconnection syndrome”? J Neurol. 2007;254(2):II18–21.PubMed Calabrese P, Penner IK. Cognitive dysfunctions in multiple sclerosis–a “multiple disconnection syndrome”? J Neurol. 2007;254(2):II18–21.PubMed
166.
Zurück zum Zitat Tillema JM, Renaud DL. Leukoencephalopathies in adulthood. Semin Neurol. 2012;32(1):85–94.PubMed Tillema JM, Renaud DL. Leukoencephalopathies in adulthood. Semin Neurol. 2012;32(1):85–94.PubMed
167.
Zurück zum Zitat Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2014;29(14):00827. Parikh S, Bernard G, Leventer RJ, van der Knaap MS, van Hove J, Pizzino A, et al. A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2014;29(14):00827.
168.
Zurück zum Zitat Flanagan EP, Knopman DS, Keegan BM. Dementia in MS complicated by coexistent Alzheimer disease: diagnosis premortem and postmortem. Neurol Clin Pract. 2014;4(3):226–30.PubMedCentralPubMed Flanagan EP, Knopman DS, Keegan BM. Dementia in MS complicated by coexistent Alzheimer disease: diagnosis premortem and postmortem. Neurol Clin Pract. 2014;4(3):226–30.PubMedCentralPubMed
Metadaten
Titel
A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis
verfasst von
Michel Toledano
Brian G. Weinshenker
Andrew J. Solomon
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 8/2015
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-015-0576-7

Weitere Artikel der Ausgabe 8/2015

Current Neurology and Neuroscience Reports 8/2015 Zur Ausgabe

Behavior (HS Kirshner, Section Editor)

Update in Aphasia Research

Dementia (KS Marder, Section Editor)

TMS as a Tool for Examining Cognitive Processing

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.